India has given a green light for emergency use of the Oxford-AstraZeneca COVID-19 vaccine COVISHIELD for emergency use.
The Central Drugs Standard Control Organisation (CDSCO), whose experts were meeting on 1st January 2021 Friday for the second time this week came to the decision that paves the way for a near-immediate start to the inoculation process, according to Reuters.
Britain last week approved the emergency authorisation of Oxford-AstraZeneca COVID-19 vaccine in the country.
Cheaper and easier to distribute than rival vaccines, the Oxford-AstraZeneca COVID-19 vaccine is by far the most significant in the global fight against the novel coronavirus. Unlike the two messenger RNA vaccines by US firms Pfizer and Moderna, this vaccine could be kept at normal refrigerator temperatures of between two and eight degrees Celsius. The Moderna vaccine needs to be stored at Minus 20C, while the Pfizer/BioNTech product must be kept at Minus 70C. It will be priced as little as $3 per dose.
Researchers claimed the vaccine protected against disease in 62% of those given two full doses and in 90% of those initially given a half dose.
India's Central Drugs Standard Control Organization (CDSCO) could also approve a vaccine locally developed by Bharat Biotech, Reuters reported. The Drugs Controller General of India will take the final decision on emergency approval of coronavirus vaccine in India based on expert committee's recommendations.
No comments:
Post a Comment